BIOMAT Database Logo BIOMAT Database Logo

Effects of in vitro exposure to nitrogen dioxide on human alveolar macrophage release of neutrophil chemotactic factor and interleukin-1. 1988

P Pinkston, and A Smeglin, and N J Roberts, and F R Gibb, and P E Morrow, and M J Utell
Department of Medicine, University of Rochester School of Medicine and Dentistry, New York 14642.

To evaluate the potential toxic and immunologic effects of nitrogen dioxide (NO2) exposure on cells from the lower respiratory tract, normal human alveolar macrophages obtained by bronchoalveolar lavage were exposed to increasing concentrations of NO2 using an in vitro exposure system. Alveolar macrophages exposed to 5, 10, or 15 ppm NO2 for 3 hr showed no difference in cell viability when compared to air-exposed macrophages. In addition, the spontaneous release of neutrophil chemotactic factor (NCF) was not changed by NO2 exposure, nor was there any effect on the ability of alveolar macrophages to release increased amounts of NCF following stimulation with activated zymosan. Furthermore, alveolar macrophages did not spontaneously release interleukin-1 (IL-1) following air or NO2 exposure. When stimulated with influenza virus both air- and NO2-exposed cells released increased amount of IL-1, but was no significant difference in the amount of IL-1 released by air- and NO2-exposed alveolar macrophages. Thus, although NO2 exposure is known to incite an inflammatory response in the lower respiratory tract, using the in vitro exposure system described in this study we were unable to demonstrate a direct toxic effect of NO2 on viability or any NO2-induced change in the release of the immunoregulatory molecules NCF and IL-1.

UI MeSH Term Description Entries
D007375 Interleukin-1 A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. IL-1,Lymphocyte-Activating Factor,Epidermal Cell Derived Thymocyte-Activating Factor,Interleukin I,Macrophage Cell Factor,T Helper Factor,Epidermal Cell Derived Thymocyte Activating Factor,Interleukin 1,Lymphocyte Activating Factor
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D008297 Male Males
D009585 Nitrogen Dioxide Nitrogen oxide (NO2). A highly poisonous gas. Exposure produces inflammation of lungs that may only cause slight pain or pass unnoticed, but resulting edema several days later may cause death. (From Merck, 11th ed) It is a major atmospheric pollutant that is able to absorb UV light that does not reach the earth's surface. Nitrogen Peroxide,Dioxide, Nitrogen,Peroxide, Nitrogen
D011650 Pulmonary Alveoli Small polyhedral outpouchings along the walls of the alveolar sacs, alveolar ducts and terminal bronchioles through the walls of which gas exchange between alveolar air and pulmonary capillary blood takes place. Alveoli, Pulmonary,Alveolus, Pulmonary,Pulmonary Alveolus
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002630 Chemotactic Factors Chemical substances that attract or repel cells. The concept denotes especially those factors released as a result of tissue injury, microbial invasion, or immunologic activity, that attract LEUKOCYTES; MACROPHAGES; or other cells to the site of infection or insult. Chemoattractant,Chemotactic Factor,Chemotaxin,Chemotaxins,Cytotaxinogens,Cytotaxins,Macrophage Chemotactic Factor,Chemoattractants,Chemotactic Factors, Macrophage,Macrophage Chemotactic Factors,Chemotactic Factor, Macrophage,Factor, Chemotactic,Factor, Macrophage Chemotactic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

P Pinkston, and A Smeglin, and N J Roberts, and F R Gibb, and P E Morrow, and M J Utell
Asbestos-induced release of a human alveolar macrophage-derived neutrophil chemotactic factor.
January 1990, Experimental lung research,
P Pinkston, and A Smeglin, and N J Roberts, and F R Gibb, and P E Morrow, and M J Utell
Regulation of the release of alveolar macrophage-derived neutrophil chemotactic factor.
April 1980, The American review of respiratory disease,
P Pinkston, and A Smeglin, and N J Roberts, and F R Gibb, and P E Morrow, and M J Utell
Comparison of neutrophil chemotactic factor release by human and rabbit alveolar macrophages in response to tannin exposure.
February 1995, The Journal of laboratory and clinical medicine,
P Pinkston, and A Smeglin, and N J Roberts, and F R Gibb, and P E Morrow, and M J Utell
Nitrogen dioxide exposure in vivo and human alveolar macrophage inactivation of influenza virus in vitro.
April 1989, Environmental research,
P Pinkston, and A Smeglin, and N J Roberts, and F R Gibb, and P E Morrow, and M J Utell
Nitrogen dioxide exposure and alveolar macrophage elastase in hamsters.
February 1982, The American review of respiratory disease,
P Pinkston, and A Smeglin, and N J Roberts, and F R Gibb, and P E Morrow, and M J Utell
Role of chemotactic factor inactivator in modulating alveolar macrophage-derived neutrophil chemotactic activity.
February 1987, The Journal of laboratory and clinical medicine,
P Pinkston, and A Smeglin, and N J Roberts, and F R Gibb, and P E Morrow, and M J Utell
Effect of exposure to nitrogen dioxide on alveolar macrophage-mediated immunosuppressive activity in rats.
April 2001, Toxicology letters,
P Pinkston, and A Smeglin, and N J Roberts, and F R Gibb, and P E Morrow, and M J Utell
Alveolar macrophage-stimulated neutrophil and monocyte migration: effects of in vitro ozone exposure.
April 1988, Toxicology and applied pharmacology,
P Pinkston, and A Smeglin, and N J Roberts, and F R Gibb, and P E Morrow, and M J Utell
Macrophage-neutrophil interactions: contrasting effects of the monokines interleukin-1 and tumour necrosis factor (cachectin) on human neutrophil adherence.
November 1987, Immunology,
P Pinkston, and A Smeglin, and N J Roberts, and F R Gibb, and P E Morrow, and M J Utell
Human alveolar macrophage cytokine release in response to in vitro and in vivo asbestos exposure.
January 1993, Experimental lung research,
Copied contents to your clipboard!